Back to Results
First PageMeta Content
Hepatitis C / HIV test / Medicine / Health / Microbiology / Hepatitis C and HIV co-infection / Hepacivac / HIV/AIDS / Hepatitis / Hepatitis C virus


Hepatitis C Virus Reinfection in Injection Drug Users Jason Grebely,1 Brian Conway,1 Jesse D. Raffa,2 Calvin Lai,4 Mel Krajden,5 and Mark W. Tyndall3,4 Spontaneous clearance of hepatitis C (HCV) may provide protection ag
Add to Reading List

Document Date: 2013-10-17 10:00:04


Open Document

File Size: 157,40 KB

Share Result on Facebook

City

Orlando / Emeryville / Mississauga / Baltimore / Vancouver / Chicago / GREBELY ET / Durham / /

Company

Hoover / Chiron / Abbott Diagnostics / Ortho Diagnostics / HCV Ab / Cox / Schering-Plough / Schering / HIV-Positive / Wiley InterScience / decrease circulating HCV-specific CD4 / /

Country

Canada / /

Currency

CAD / /

/

Event

FDA Phase / /

Facility

University of British Columbia / British Columbia Centre / University of British Columbia Virology Department / University of British Columbia /Providence Health Care Research Ethics Board / Paul’s Hospital / Laboratory Testing / /

/

IndustryTerm

Treatment of hepatitis C / selected / injection equipment / utilized health services / treatment for hepatitis C / treatment for HCV / /

MedicalCondition

HIV / HBV / epidemic / viremia following reexposure / chronic hepatitis C. HEPATOLOGY / incident infection / hepatitis C / hepatitis B / primary infection / virus infections / subsequent infection / HIV infections / low-level viremia / acute and chronic HCV / successive hepatitis C / spontaneously clearing viremia / persistent viremia / HIV infection / HBV infection / disease / acute hepatitis / HCV / viremia / persistent hepatitis C / virus infection / persistent infection / hepatitis C. Lancet / AIDS / HIV/AIDS / infection / prior infection / et al. Hepatitis C / chronic hepatitis C / individuals developing viremia / /

MedicalTreatment

antiviral therapy / /

Organization

University of British Columbia /Providence Health Care Research Ethics Board / Michael Smith Foundation for Health Research / University of British Columbia / Vancouver / St. Paul’s Hospital / 4BC Centre for Excellence / American Association for the Study of Liver Diseases / Department of Anesthesiology / Pharmacology and Therapeutics / University of British Columbia Virology Department / British Columbia Centre for Disease Control / Natural Sciences and Engineering Research Council of Canada / 5BC Centre for Disease Control / /

Person

Krajden / Prince / Van Ameijden / Conway / Jason Grebely / /

Position

Martin MP / Manns MP / physician / consultant / Prince / Major / Fisher / /

Product

Peginterferon / Abbreviations / ribavirin / Previous HBV infection Unstable housing Illicit drug use Any Frequent Injection / Any Frequent Injection / HCV / CD4 / /

ProvinceOrState

Alabama / British Columbia / Ontario / /

RadioStation

Prince AM / /

Technology

antibodies / transplantation / genotype / /

URL

www.interscience.wiley.com / /

SocialTag